Delivery Order SPE2DB24D1205-SPE2DB25FCSYQ
Award Date
1/10/25
Potential Completion Date
1/13/25
Potential Value
$2.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of M-M-R II vaccine vials to the Defense Logistics Agency (DLA) by Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract has a ceiling value of $2,049.52 and is a firm fixed price delivery order that runs through May 9, 2024.
Amerisourcebergen, through its Corporate Office division, holds a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 with the DLA Troop Support Medical to provide a...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of M-M-R II vaccine vials. The contract, valued at $54,270.30, is a firm-fixed-price delivery order with a period of performance through June 26, 2024. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $15,053.96 firm fixed price delivery order contract to provide M-M-R II vaccine vials. This award is part of a larger, single-award indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp valued at up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary vehicle for Amerisourcebergen to deliver pharmaceuticals and medical...
The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $1,537.14 firm fixed price delivery order contract to provide M-M-R II vaccine vials. The contract has a completion date of February 28, 2024. Amerisourcebergen Drug Corp serves as a prime contractor providing pharmaceutical products and medical supplies to U.S. government agencies, including the Department of Defense. This award is part of Amerisourcebergen's indefinite...
This federal contract award to Amerisourcebergen Drug Corp (DUNS: TGxsdkVQRGhOYUpNR001SFhYRERNdz09) is a $2,168.76 firm fixed price delivery order from the Defense Logistics Agency (DLA) for the supply of M-M-R II vaccine vials. The contract has an ultimate completion date of November 15, 2024. Amerisourcebergen is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies. The company holds a...
This federal contract award is for the delivery of M-M-R II vaccine vials to the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The delivery order has a firm fixed price ceiling value of $25,619.00 and a period of performance through April 12, 2024. This award is not...
The federal contract award is for the delivery of M-M-R II vaccine vials to the Defense Logistics Agency (DLA), a defense agency. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $5,559.44 and an ultimate completion date of December 4, 2024. It is a delivery order contract with a firm fixed price pricing type. The contract is not designated with any set-aside requirements, indicating...
This federal contract award is for the procurement of M-M-R II vaccine vials by the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award has a ceiling value of $2,824.91 and is a firm fixed price delivery order contract that runs through December 6, 2024. There is no set-aside designation for this award. AmerisourceBergen holds a $999,999,999 Indefinite...
The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide M-M-R II vaccine vials. The contract is valued at $3,737.16 and has a completion date of March 4, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation for this award. The contract is part of a larger indefinite delivery contract (IDC) valued up to $999,999,999.00...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office Division for the provision of M-M-R II vaccine vials. The delivery order, valued at $5,655.61, was issued under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of up to $999,999,999.00 through December 31, 2025. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a...